Cassava Sciences Inc

SAVA NASDAQ
1.157
-0.033
-2.80%
Closed 16:00 08/23 EDT
Open
1.200
Prev Close
1.190
High
1.230
Low
1.150
Volume
106.15K
Avg Vol (3M)
231.46K
52 Week High
2.990
52 Week Low
0.7600
% Turnover
0.62%
Market Cap
19.92M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Cassava Sciences Inc SAVA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Cassava Sciences, Inc., formerly Pain Therapeutics, Inc., is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer’s. Its drug candidate, PTI-125, is a small molecule that targets an altered form of a scaffolding protein called filamin A (FLNA). It is also developing an experimental biomarker/diagnostic, PTI-125Dx. It is developing PTI-125Dx to detect Alzheimer’s disease with a blood test.
MORE >

Recently

Name
Price
%Change